IMPACT Program: care at 3 levels: (1) co-definition of the health situation, (2) co-planning of care and co-actions, and (3) co-assessment with the patient and with the team caring for him or her, and incorporating evidence-based measurement tools.
usal care: usual management with a Nurse in Advanced Practice.
The WHO and our governance advocate that health professionals should organize care around the patient, considering his or her values, needs and preferences, and enabling the patient to develop the capacity to self-manage the chronic health problems he or she faces. Chronic disease is an ongoing dynamic process and adaptation to this process is complicated by the interaction of several determinants: self-management capacity, level of health literacy, quality of life and experience of care. To best support chronic disease, the recommendation is to adopt a management strategy that allows chronic patients to play an active role in the management of their condition and in the day-to-day decision-making process. The management of chronic pathologies is one of the specialties in which Advanced Practice Nurses are positioned, in primary care, outside hospital. Nursing care benefits from care models that allow for more adapted responses, regarding particular care situations, or certain patient typologies. The Humanistic Partnership Health Care Model (MPHS) implement in current Advanced Practice Nurse (APN) practice.
| Facility | City | Region | Status |
|---|---|---|---|
| CH le Corbusier - Firminy | Firminy | France | Not Yet Recruiting |
| Hôpital du Gier | Saint-Chamond | France | Not Yet Recruiting |
| Centre Hospitalier Universitaire - Pneumologie | Saint-Etienne | France | Not Yet Recruiting |
| Centre Hospitalier Universitaire - Cardiologie | Saint-Etienne | France | Not Yet Recruiting |
| Direction de la Prévention et de la Santé des Populations | Saint-Etienne | France | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05780762 on ClinicalTrials.gov ↗ ← All trials in France